Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Allergan NYSE:AGN |
63,79 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Jazz Pharmaceuticals NasdaqGS:JAZZ |
11,75 B | 8,10% | 2/6 | 79,55% | -60,00% | 18,10% | UP |
|
Alkermes NasdaqGS:ALKS |
5,49 B | 18,29% | 5/6 | 17,01% | 15,98% | 30,22% | UP |
|
Glanbia ISE:GL9 |
4,13 B | 4,55% | 5/6 | 5,11% | -32,22% | 10,34% | UP |
|
Avadel Pharmaceuticals NasdaqGM:AVDL |
2,12 B | 6,52% | 3/6 | 26,48% | -64,98% | -100,00% | UP |
|
Cosmo Pharmaceuticals N.V. SWX:COPN |
1,39 B | 12,72% | 4/6 | 174,36% | -102,54% | 49,51% | UP |
|
Perrigo NYSE:PRGO |
1,45 B | -5,73% | 0/6 | -11,32% | 64,90% | 56,25% | DOWN |
|
GH Research PLC NasdaqGM:GHRS |
0,91 B | 0,00% | 0/4 | 0,00% | 0,00% | 148,64% | UP |
|
Amryt Pharma NasdaqGM:AMYT |
0,47 B | 24,85% | 0/0 | 0,00% | 0,00% | 0,00% | DOWN |
|
Amarin NasdaqCM:AMRN |
0,31 B | -7,83% | 1/6 | -295,06% | -726,77% | -18,31% | DOWN |
|
Ovoca Bio AIM:OVB |
0,00 B | 0,00% | 2/2 | 0,00% | 0,00% | -100,00% | DOWN |
